Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: results of CALGB protocol 7113.
Henderson ES, Scharlau C, Cooper MR, Haurani FI, Silver RT, Brunner K, Carey RW, Falkson G, Blom J, Nawabi IV, Levine AS, Bank A, Cuttner J, Cornwell GG 3rd, Henry P, Nissen NI, Wiernik PH, Leone L, Wohl H, Rai K, James GW, Weinberg V, Glidewell O, Holland JF. Henderson ES, et al. Among authors: haurani fi. Leuk Res. 1979;3(6):395-407. doi: 10.1016/0145-2126(79)90036-5. Leuk Res. 1979. PMID: 297176 Clinical Trial. No abstract available.
Daunorubicin in the therapy of acute granulocytic leukemia.
Weil M, Glidewell OJ, Jacquillat C, Levy R, Serpick AA, Wiernik PH, Cuttner J, Hoogstraten B, Wasserman L, Ellison RR, Gailani S, Brunner K, Silver RT, Rege VB, Cooper MR, Lowenstein L, Nissen NI, Haurani F, Blom J, Boiron M, Bernard J, Holland JF. Weil M, et al. Cancer Res. 1973 May;33(5):921-8. Cancer Res. 1973. PMID: 4512953 No abstract available.
Daunorubicin (NSC-83142) versus daunorubicin plus prednisone (NSC-10023) versus daunorubicin plus vincristine (NSC-67574) plus prednisone in advanced childhood acute lymphocytic leukemia.
Jones B, Cuttner J, Levy RN, Patterson RB, Kung F, Pleuss HJ, Falkson G, Treat CL, Haurani F, Burgert EO Jr, Rosner F, Carey RW, Lukens J, Blom J, Degnan TJ, Wohl H, Glidewell O, Holland JF. Jones B, et al. Cancer Chemother Rep. 1972 Dec;56(6):729-37. Cancer Chemother Rep. 1972. PMID: 4574054 Clinical Trial. No abstract available.
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study.
Yates J, Glidewell O, Wiernik P, Cooper MR, Steinberg D, Dosik H, Levy R, Hoagland C, Henry P, Gottlieb A, Cornell C, Berenberg J, Hutchison JL, Raich P, Nissen N, Ellison RR, Frelick R, James GW, Falkson G, Silver RT, Haurani F, Green M, Henderson E, Leone L, Holland JF. Yates J, et al. Blood. 1982 Aug;60(2):454-62. Blood. 1982. PMID: 6953986 Free article. Clinical Trial.
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B.
Nissen NI, Pajak TF, Glidewell O, Pedersen-Bjergaard J, Stutzman L, Falkson G, Cuttner J, Blom J, Leone L, Sawitsky A, Coleman M, Haurani F, Spurr CL, Harley JB, Seligman B, Cornell C Jr, Henry P, Senn HJ, Brunner K, Martz G, Maurice P, Bank A, Shapiro L, James GW, Holland JF. Nissen NI, et al. Cancer. 1979 Jan;43(1):31-40. doi: 10.1002/1097-0142(197901)43:1<31::aid-cncr2820430104>3.0.co;2-y. Cancer. 1979. PMID: 367570 Clinical Trial.
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B.
Rai KR, Holland JF, Glidewell OJ, Weinberg V, Brunner K, Obrecht JP, Preisler HD, Nawabi IW, Prager D, Carey RW, Cooper MR, Haurani F, Hutchison JL, Silver RT, Falkson G, Wiernik P, Hoagland HC, Bloomfield CD, James GW, Gottlieb A, Ramanan SV, Blom J, Nissen NI, Bank A, Ellison RR, Kung F, Henry P, McIntyre OR, Kaan SK. Rai KR, et al. Blood. 1981 Dec;58(6):1203-12. Blood. 1981. PMID: 6946847 Free article. Clinical Trial. No abstract available.
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease.
Cooper MR, Pajak TF, Nissen NI, Stutzman L, Brunner K, Cuttner J, Falkson G, Grunwald H, Bank A, Leone L, Seligman BR, Silver RT, Weiss RB, Haurani F, Blom J, Spurr CL, Glidewell OJ, Gottlieb AJ, Holland JF. Cooper MR, et al. Cancer. 1980 Aug 15;46(4):654-62. doi: 10.1002/1097-0142(19800815)46:4<654::aid-cncr2820460405>3.0.co;2-a. Cancer. 1980. PMID: 7397630 Clinical Trial.
Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia.
Jones B, Holland JF, Morrison AR, Lee SL, Sinks LF, Cuttner J, Rausen A, Kung F, Pluss HJ, Haurani FI, Patterson RB, Blom J, Burgert EO Jr, Moon JH, Chevalier L, Sawitsky A, Albala MM, Forcier RJ, Falkson G, Glidewell O. Jones B, et al. Among authors: haurani fi. Cancer Res. 1971 Feb;31(2):84-90. Cancer Res. 1971. PMID: 5278102 No abstract available.
68 results